Barclays
ZEPP

Barclays’s Zepp Health ZEPP Stock Holding History

Barclays’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.1K Sell
7,291
-2,475
-25% -$50.7K ﹤0.01% 4085
2025
Q4 		$263K Sell
9,766
-4,281
-30% -$153K ﹤0.01% 4180
2025
Q3 		$643K Buy
+14,047
New +$426K ﹤0.01% 3640
2020
Q4 		– Sell
-6,675
Closed -$343K – 5187
2020
Q3 		$343K Hold
6,675
– – ﹤0.01% 3495
2020
Q2 		$330K Buy
+6,675
New +$308K ﹤0.01% 3663
2019
Q3 		– Sell
-632
Closed -$25K – 7188
2019
Q2 		$25K Buy
+632
New +$26.4K ﹤0.01% 6365

Other funds holding ZEPP

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MM
Monolith Management Hong Kong $332M AUM 119.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Barclays's ZEPP Position: Q1 2026 in Review

Barclays reduced its Zepp Health (ZEPP) stake by 25% in Q1 2026, selling an estimated $50.7K and leaving 7,291 shares worth $87.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

Barclays first reported a position in ZEPP in Q2 2019 and has held it in 6 quarters since. The position peaked at $643K in Q3 2025. 32 funds tracked by Wall St. Rank hold ZEPP as of Q1 2026.

  • Barclays held 7,291 shares of Zepp Health worth $87.1K as of Q1 2026.
  • Barclays sold 2,475 Zepp Health shares in Q1 2026, an estimated $50.7K.
  • Zepp Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4085 holding.
  • Barclays first reported a position in Zepp Health in Q2 2019 and has held it in 6 quarters since.
  • Barclays's Zepp Health position peaked at $643K in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Zepp Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.